Advertisement
Screener

EyePoint, Inc. (EYPT) Deferred Foreign Income Tax Expense (Benefit)

2.5 / 5 stars · 47/94 Roast Me

EyePoint, Inc. Deferred Foreign Income Tax Expense (Benefit)

EyePoint, Inc. (EYPT) reported Deferred Foreign Income Tax Expense (Benefit) of $0 for the 12-month period ending 2015-06-30, per its 10-K filed 2015-09-10.

Discontinued › Expense Statement › Income Tax

us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2015-09-10

  • EyePoint, Inc. deferred foreign income tax expense (benefit) for fiscal 2015 was $0.00.
  • EyePoint, Inc. deferred foreign income tax expense (benefit) for fiscal 2014 was $0.00.
  • EyePoint, Inc. deferred foreign income tax expense (benefit) for fiscal 2013 was $0.00.
Period endDeferred Foreign Income Tax Expense (Benefit) 12 month
2015-06-30$0.00
10-K · filed 2015-09-10
2014-06-30$0.00
10-K · filed 2015-09-10
2013-06-30$0.00
10-K · filed 2015-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15